loadpatents
Patent applications and USPTO patent grants for YLA-HERTTUALA; Seppo.The latest application filed is for "synthetic microrna mimics".
Patent | Date |
---|---|
Synthetic Microrna Mimics App 20220186228 - TURUNEN; Mikko Petri ;   et al. | 2022-06-16 |
Fixed-bed bioreactor with constant-flow pump / tubing system Grant 11,261,416 - Valonen , et al. March 1, 2 | 2022-03-01 |
Aseptic bioreactor sampling system Grant 11,242,504 - Valonen , et al. February 8, 2 | 2022-02-08 |
Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity App 20200354409 - TURKKI; Vesa ;   et al. | 2020-11-12 |
Nucleic acid application primers Grant 10,829,785 - Lesch , et al. November 10, 2 | 2020-11-10 |
Method to Curtail the Progression of Non-Muscle Invasive Bladder Cancer To Muscle-Invasive Cancer App 20200222477 - PARKER; Nigel ;   et al. | 2020-07-16 |
Transgene-Cytotoxic Combination Therapy App 20200101100 - SAMARANAYAKE; Haritha ;   et al. | 2020-04-02 |
Nucleic Acid Application Primers App 20200071725 - Lesch; Hanna P. ;   et al. | 2020-03-05 |
Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion Time App 20190276846 - LIPPONEN; Eevi ;   et al. | 2019-09-12 |
Anti-Angiogenic Gene Therapy Kit App 20190275106 - YLA-HERTTUALA; Seppo ;   et al. | 2019-09-12 |
Combination Therapy For Cancer App 20170348345 - SAMARANAYAKE; Haritha ;   et al. | 2017-12-07 |
Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion Time App 20170051309 - LESCH; Hanna P. ;   et al. | 2017-02-23 |
Production of Lentiviral Vectors App 20170016028 - YLA-HERTTUALA; Seppo ;   et al. | 2017-01-19 |
Production of Vectors for Non-Dividing Host Cells App 20160097060 - LESCH; Hanna P. ;   et al. | 2016-04-07 |
Treatment of Operable High-Grade Glioma With Sitimagene Ceradenovec Gene Therapy and Ganciclovir App 20160058888 - Yla-Herttuala; Seppo | 2016-03-03 |
Anti-Angiogenic Gene Therapy With Soluble VEGF Receptors -1, -2 and -3 Together With Paclitaxel Prolongs Survival Of Mice With Human Ovarian Carcinoma App 20140057851 - YLA-HERTTUALA; Seppo | 2014-02-27 |
Transfection of Mesothelium Body Cavity Lining with Gene Agents Followed by Chemotharapy to Treat Cancer of Organs in the Body Cavity App 20140017204 - PARKER; Nigel ;   et al. | 2014-01-16 |
Transfection of Mesothelium Body Cavity Lining with Gene Agents Followed by Chemotharapy to Treat Cancer of Organs in the Body Cavity App 20140017202 - PARKER; Nigel ;   et al. | 2014-01-16 |
Combination Therapy for Cancer App 20130331442 - SAMARANAYAKE; Haritha ;   et al. | 2013-12-12 |
Combination Therapy for Cancer App 20130310444 - Samaranayake; Haritha ;   et al. | 2013-11-21 |
Combination Therapy for Cancer App 20130296407 - SAMARANAYAKE; Haritha ;   et al. | 2013-11-07 |
Use of VEGF-D gene to prevent restenosis Grant 8,455,453 - Alitalo , et al. June 4, 2 | 2013-06-04 |
Therapeutic Use of Growth Factor, and Delivery Device, Especially for the Treatment of Intimal Hyperplasia App 20120308522 - MARTIN; John Francis ;   et al. | 2012-12-06 |
VEGF-D mutants and their use Grant 8,188,039 - Toivanen , et al. May 29, 2 | 2012-05-29 |
Modified Vegf-a With Improved Angiogenic Properties App 20120071406 - ALITALO; KARI ;   et al. | 2012-03-22 |
Modified VEGF-A with improved angiogenic properties Grant 8,025,886 - Alitalo , et al. September 27, 2 | 2011-09-27 |
VEGF-D Mutants and Their Use App 20110144013 - Toivanen; Pyry ;   et al. | 2011-06-16 |
Non-Aggregating Virus Formulation App 20110052540 - Shaw; Robert ;   et al. | 2011-03-03 |
Method for Incorporating Proteins Into Lentivirus Vectors App 20100221791 - Schenkwein; Diana ;   et al. | 2010-09-02 |
Use of VEGF-C or VEGF-D in Reconstructive Surgery App 20100041605 - Alitalo; Kari ;   et al. | 2010-02-18 |
Production of Lentiviral Vectors App 20100003746 - Lesch; Hanna P. ;   et al. | 2010-01-07 |
Engineered Baculoviruses and Their Use App 20090176660 - Yla-Herttuala; Seppo ;   et al. | 2009-07-09 |
Avidin-Pseudotyped Viral Vectors and Their Use App 20090047733 - Airenne; Kari Juhani ;   et al. | 2009-02-19 |
Integrase Fusion Proteins And Their Use With Integrating Gene Therapy App 20090011509 - Ahlroth; Mervi ;   et al. | 2009-01-08 |
Biotin-binding receptor molecules App 20090011984 - Yla-Herttuala; Seppo ;   et al. | 2009-01-08 |
Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia App 20080305999 - Martin; John Francis ;   et al. | 2008-12-11 |
Pseudotyped Baculovirus and its Use App 20080280363 - Airenne; Kari Juhani ;   et al. | 2008-11-13 |
Baculovirus-Based Gene Libraries App 20080280783 - Airenne; Kari Juhani ;   et al. | 2008-11-13 |
Peptides and their use in assays for cardiovascular disease App 20080261234 - Narvanen; Outi ;   et al. | 2008-10-23 |
Avidin-pseudotyped viral vectors and their use Grant 7,393,677 - Airenne , et al. July 1, 2 | 2008-07-01 |
Use of VEGF-C or VEGF-D in Reconstructive Surgery App 20080147045 - Alitalo; Kari ;   et al. | 2008-06-19 |
Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia Grant 7,320,679 - Martin , et al. January 22, 2 | 2008-01-22 |
Expression Cassette App 20070224675 - Airenne; Kari Juhani ;   et al. | 2007-09-27 |
Modified VEGF-A with improved angiogenic properties App 20070142282 - Alitalo; Kari ;   et al. | 2007-06-21 |
Nucleic acids encoding biotin-binding receptors Grant 7,208,291 - Yla-Herttuala , et al. April 24, 2 | 2007-04-24 |
Avidin-pseudotyped viral vectors and their use App 20060246091 - Airenne; Kari Juhani ;   et al. | 2006-11-02 |
Periadventitial delivery device App 20060093653 - Martin; John Francis ;   et al. | 2006-05-04 |
Use of VEGF-C or VEGF-D gene or protein to prevent restenosis App 20050256075 - Alitalo, Kari ;   et al. | 2005-11-17 |
Use of VEGF-C to prevent restenosis Grant 6,958,147 - Alitalo , et al. October 25, 2 | 2005-10-25 |
Engineered baculoviruses and their use App 20050201983 - Yla-Herttuala, Seppo ;   et al. | 2005-09-15 |
Use of VEGF-C or VEGF-D in reconstructive surgery App 20050043235 - Alitalo, Kari ;   et al. | 2005-02-24 |
Medical device App 20050002981 - Lahtinen, Mika ;   et al. | 2005-01-06 |
VEGF-B and PDGF modulation of stem cells App 20040248796 - Alitalo, Kari ;   et al. | 2004-12-09 |
Gene delivery of a viral vector App 20040208905 - Yla-Herttuala, Seppo ;   et al. | 2004-10-21 |
Biotin-binding receptor molecules App 20040185059 - Yla-Herttuala, Seppo ;   et al. | 2004-09-23 |
Avidin pseudotyped viral vectors and their use App 20040146487 - Airenne, Kari Juhani ;   et al. | 2004-07-29 |
Peptides and their use in assays for cardiovascular disease App 20040091934 - Narvanen, Outi ;   et al. | 2004-05-13 |
Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia App 20030225020 - Martin, John Francis ;   et al. | 2003-12-04 |
Combination for the treatment of endothelial damage App 20030099687 - Alitalo, Kari ;   et al. | 2003-05-29 |
Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds App 20030064954 - Urtti, Arto ;   et al. | 2003-04-03 |
Periadventitial delivery device App 20030039694 - Martin, John Francis ;   et al. | 2003-02-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.